GPR132 did not reach statistical significance in the TCGA cohort (log-rank p = 0.186) and did not enhance the prognostic power when combined with APOD (Fig. 3 E).
← all excerpts
Identification of predictive pretreatment biomarkers for neoadjuvant chemotherapy response in Latino invasive breast cancer patients.
1
0.1860
0.1860